Reaction: Fingolimod to 1 product

Reaction
Reaction type
Not Available
Direction
Major circulating metabolite?
No
Spontaneous?
No
Activity
unknown
References
  1. David OJ, Kovarik JM, Schmouder RL: Clinical pharmacokinetics of fingolimod. Clin Pharmacokinet. 2012 Jan 1;51(1):15-28. doi: 10.2165/11596550-000000000-00000. [Article]
  2. FDA Approved Products: Gilenya (fingolimod) oral capsules [Link]
Comments
Not Available
Enzymes
EnzymeKmVmaxRole
Sphingosine kinase 1Not AvailableNot Availableimplied